ALISON HIATT: Open Payments
NPI 1891045217 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 39 payments from 26 companies in 2025. Trend: 2023 $625 · 2024 $669 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Janssen Biotech, Inc. | 4 | $75 |
| ABBVIE INC. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Incyte Corporation | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Aveo Pharmaceuticals, Inc. | 1 | $29 |
Products named: KEYTRUDA, ENHERTU, DARZALEX, LIBTAYO, NINLARO, FOTIVDA, LONSURF, VERZENIO.
Industry payments across KS — which companies pay providers there.
